Lepu Biopharma Co., Ltd.

HK$2.88As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2157Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (17.57%)
Div yield —
ROE 24.24%
Biotechnology
Beta (5Y) (0.36)
PE TTM 18.20
TSR TTM (54.65%)
Mkt cap HK$5.197B
ROIC (0.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.41
18.53%
(22.28%)
Hold 0|2|3|1|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.06
0.06
0.06
0.06
5.70%
11.01%
3.51%
8.63%
Revenue¥M
234.8
243.8
256.3
263.6
1.97%
4.75%
11.29%
13.68%
Peers (US$662.9M)
Cap (US$)
PE
666.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.896
0.027
0.026
EBIT/Intx
0.814
0.503
0.418
Own earn%
(905.69)
75.32
48.84
Sh yield%
27.82
39.97
35.58
Owners
Insiders/Inst%
4.94
80.96
Short interest%
1.65
SBC / revenue%
1.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
30–35
$1 testx
—
Incr. ROIC%
21